Concepedia

Scott E. Szafranski

SE

Statistics

Publications

5

Citations

279

H-Index

5

Active since

2010

Affiliations

Duke Medical Center(Current)

Duke University Hospital

Duke University

National Cancer Institute

Center for Cancer Research

Scott E. Szafranski is an author at Duke Medical Center specializing in oncology, pharmacology, and cancer immunotherapy.

Publications per year

2010–2018

5

Publications

5

Recombinant anti‐podoplanin (NZ‐1) immunotoxin for the treatment of malignant brain tumors

Vidyalakshmi Chandramohan, Xuhui Bao, Mika K. Kaneko et al. · International Journal of Cancer · 2012 · 76 citations · Full text

, , +17

Construction of an Immunotoxin, D2C7-(scdsFv)-PE38KDEL, Targeting EGFRwt and EGFRvIII for Brain Tumor Therapy

Vidyalakshmi Chandramohan, Xuhui Bao, Stephen T. Keir et al. · Clinical Cancer Research · 2013 · 67 citations

, , +17

A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma

Patrick C. Gedeon, Teilo Schaller, Satish K. Chitneni et al. · Clinical Cancer Research · 2018 · 56 citations · Full text

, , +17

MRP3: a molecular target for human glioblastoma multiforme immunotherapy.

Chien-Tsun Kuan, Kenji Wakiya, James E. Herndon et al. · BMC Cancer · 2010 · 53 citations · Full text

, , +17

Production and quality control assessment of a GLP-grade immunotoxin, D2C7-(scdsFv)-PE38KDEL, for a phase I/II clinical trial

Vidya Chandramohan, Charles N. Pegram, Hailan Piao et al. · Applied Microbiology and Biotechnology · 2016 · 27 citations · Full text

, , +9

1–5 of 5